Procaps Group S.A. (PROC)

NASDAQ: PROC · IEX Real-Time Price · USD
2.900
+0.200 (7.41%)
Mar 28, 2024, 9:40 AM EDT - Market closed
7.41%
Market Cap 327.21M
Revenue (ttm) 414.10M
Net Income (ttm) 52.20M
Shares Out 112.82M
EPS (ttm) 0.52
PE Ratio 5.58
Forward PE 31.59
Dividend n/a
Ex-Dividend Date n/a
Volume 1,090
Open 2.870
Previous Close 2.700
Day's Range 2.870 - 2.900
52-Week Range 1.950 - 5.380
Beta 0.13
Analysts Hold
Price Target 4.50 (+55.17%)
Earnings Date May 10, 2024

About PROC

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers ... [Read more]

Sector Healthcare
Founded 1976
Employees 5,500
Stock Exchange NASDAQ
Ticker Symbol PROC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for PROC stock is "Hold" and the 12-month stock price forecast is $4.5.

Price Target
$4.5
(55.17% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Procaps Group – Notice to Shareholders

MIAMI & BARRANQUILLA, Colombia.--(BUSINESS WIRE)--Dear Shareholders, We became aware on Saturday, January 13, 2024, that the online voting instructions related to the upcoming General Meeting of Share...

2 months ago - Business Wire

Procaps Group Reports Third Quarter 2023 Results

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Reports Third Quarter 2023 Results.

3 months ago - Business Wire

Statement from the Board of Directors of Procaps Group

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Statement from the Board of Directors of Procaps Group.

3 months ago - Business Wire

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Agreement Combines Procaps Oral Delivery System Technology and Manufacturing with Genomma's Strategic Marketing and Distribution Footprint BARRANQUILLA, Colombia and MEXICO CITY and MIAMI , Nov. 29, 2...

4 months ago - PRNewsWire

Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024.

4 months ago - Business Wire

Procaps Group Update on Third Quarter Results

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Update on Third Quarter Results.

4 months ago - Business Wire

Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Report Third Quarter and Nine Months Results on Tuesday November 14 and Host Conference Call on Thursday November 16 at 10:30a.m. ET.

4 months ago - Business Wire

Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia.

5 months ago - Business Wire

Procaps Group to Participate at CPHI Barcelona 2023

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will participa...

5 months ago - Business Wire

Procaps Group to Host Webinar on Colombian Pharma Market

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Host Webinar on Colombian Pharma Market Tuesday, October 10, 2023 at 10:00 a.m. Eastern Time.

6 months ago - Business Wire

Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October.

7 months ago - Business Wire

Procaps Group Announces the Expansion of its Oncology Portfolio

MIAMI & BARRANQUILLA, Columbia--(BUSINESS WIRE)--Procaps Group Announces the Expansion of its Oncology Portfolio.

7 months ago - Business Wire

Procaps Group Reports Second Quarter 2023 Results

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Reports Second Quarter 2023 Results.

7 months ago - Business Wire

Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday.

7 months ago - Business Wire

Procaps Group Publishes White Paper on Innovative Gummy Technology

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Publishes White Paper on Innovative Gummy Technology.

8 months ago - Business Wire

Procaps Group Reports First Quarter 2023 Results

Constant Currency Net Revenues Increased 10% Quarter-over-Quarter in 1Q23, and 22% increase in Adjusted EBITDA, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty Covid Port...

10 months ago - GlobeNewsWire

Procaps Group Reports Fourth Quarter and Full Year 2022 Results

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Reports Fourth Quarter and Full Year 2022 Results.

11 months ago - Business Wire

Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing

MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerat...

11 months ago - GlobeNewsWire

Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance

Reports Preliminary Financial Estimates for Net Revenue and Adjusted EBITDA for Full Year 2022

1 year ago - GlobeNewsWire

Procaps Announces Key Changes to the Board of Directors

International Corporate Executive and Attorney Alberto Eguiguren Correa Appointed to Board of Directors International Corporate Executive and Attorney Alberto Eguiguren Correa Appointed to Board of Di...

1 year ago - GlobeNewsWire

Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar

Company to Provide 2023 Value Creation Plan at J.P. Morgan Healthcare Conference Company to Provide 2023 Value Creation Plan at J.P. Morgan Healthcare Conference

1 year ago - GlobeNewsWire

Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference

MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomera...

1 year ago - GlobeNewsWire

Update on Proposed Acquisition of Grupo Somar

MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate,...

1 year ago - GlobeNewsWire

Procaps Group Reports Third Quarter and Nine Months 2022 Results

Constant currency Net Revenues Increased by 15% year-over-year in the 9M22 and by 11% in the 3Q22, signaling a strong demand across our businesses Constant currency Net Revenues Increased by 15% year-...

1 year ago - GlobeNewsWire

Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it e...

1 year ago - GlobeNewsWire